COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials (CanSino Biologics Inc)

COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials (CanSino Biologics Inc) (real clinical drug)

active
Code40712911000001109
Semantic tagreal clinical drug
Moduleuk-clinical
Definitiondefined
Effective time20260506

Parents (2)

Children (0)

None (leaf concept).